Bank of America’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-84
Closed -$127 7099
2023
Q2
$127 Hold
84
﹤0.01% 6513
2023
Q1
$147 Sell
84
-8
-9% -$14 ﹤0.01% 6616
2022
Q4
$174 Buy
92
+40
+77% +$76 ﹤0.01% 6744
2022
Q3
$0 Sell
52
-20
-28% ﹤0.01% 7538
2022
Q2
$0 Hold
72
﹤0.01% 7796
2022
Q1
$1K Sell
72
-4
-5% -$56 ﹤0.01% 7360
2021
Q4
$1K Sell
76
-46
-38% -$605 ﹤0.01% 7262
2021
Q3
$4K Sell
122
-46
-27% -$1.51K ﹤0.01% 6891
2021
Q2
$6K Sell
168
-4,051
-96% -$145K ﹤0.01% 6586
2021
Q1
$175K Buy
4,219
+4,020
+2,020% +$167K ﹤0.01% 5461
2020
Q4
$12K Sell
199
-239
-55% -$14.4K ﹤0.01% 5922
2020
Q3
$59K Buy
438
+218
+99% +$29.4K ﹤0.01% 5311
2020
Q2
$37K Sell
220
-107
-33% -$18K ﹤0.01% 5513
2020
Q1
$47K Sell
327
-447
-58% -$64.2K ﹤0.01% 5298
2019
Q4
$255K Buy
774
+24
+3% +$7.91K ﹤0.01% 4701
2019
Q3
$375K Buy
750
+111
+17% +$55.5K ﹤0.01% 4526
2019
Q2
$388K Sell
639
-25
-4% -$15.2K ﹤0.01% 4513
2019
Q1
$406K Buy
664
+206
+45% +$126K ﹤0.01% 4451
2018
Q4
$168K Sell
458
-178
-28% -$65.3K ﹤0.01% 4912
2018
Q3
$430K Buy
636
+414
+186% +$280K ﹤0.01% 4388
2018
Q2
$193K Buy
222
+217
+4,340% +$189K ﹤0.01% 4737
2018
Q1
$6K Sell
5
-31
-86% -$37.2K ﹤0.01% 5989
2017
Q4
$53K Buy
36
+30
+500% +$44.2K ﹤0.01% 5254
2017
Q3
$13K Hold
6
﹤0.01% 5654
2017
Q2
$16K Buy
+6
New +$16K ﹤0.01% 5525
2016
Q2
Hold
0
-$1K 6520
2016
Q1
Hold
0
6054